Century Therapeutics

Company snapshot

Century Therapeutics is an innovative biotechnology company that is building an industry-leading, allogeneic, iPSC-derived cell therapy platform that integrates cutting-edge gene editing, protein engineering, technical development and manufacturing capabilities to generate allogeneic, iPSC-derived therapies for autoimmune diseases and cancer. Please note: Century Therapeutics does not solicit pros

• 10 active pipeline program(s) linked via ClinicalTrials.gov.
• 39 US patent(s) indexed to this assignee profile.
• 10 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Century Therapeutics. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Century Therapeutics.

1. Jun 8, 2026 Clinical update

   CNTY-LTFU-01 — Phase 1

2. Jun 8, 2026 Clinical update

   CNTY-101-151-01 — Phase 1

3. Jun 8, 2026 Clinical update

   Nicotine gum (C) — Phase 1

4. Jun 5, 2026 Clinical update

   Stromal-vascular fraction — Phase 2

5. Jun 5, 2026 Clinical update

   DAOSiN®/ Placebo & ProvokAmin® Ingestion — Unknown

View all clinical trial activity →

• What is Century Therapeutics?

  Century Therapeutics is a biotech organization headquartered in Philadelphia, USA. It trades on NYSE under ticker IPSC. Primary therapeutic focus areas include Hematological or solid tumor malignancies or autoimmune diseases, Intracerebral Haemorrhage, R/R CD19-Positive B-Cell Ma

• Is Century Therapeutics publicly traded?

  Yes. Century Therapeutics is listed with ticker IPSC on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Century Therapeutics develop or market?

  We link 9 drug profile(s) where Century Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/century-therapeutics#company-drugs.

• What are the latest developments for Century Therapeutics?

  In the last 12 months our linked public records show 10 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Century Therapeutics focus on?

  Century Therapeutics focuses on Hematological or solid tumor malignancies or autoimmune diseases, Intracerebral Haemorrhage, R/R CD19-Positive B-Cell Malignancies based on our analysis of their pipeline programs and drug development activities.